This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04551/identifier/chebi/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04551/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04551/identifier/pubchem-compound/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04551/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04551/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04551
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB04551 n13:DB04551
dcterms:title
Fructose-1,6-Diphosphate
adms:identifier
n9:46937007 n10:46506743 n11:DB04551 n12:FBP n14:28013
n5:synthesisReference
Hiroshi Nakajima, Masaaki Onda, Ryoichi Turutani, Hayato Ishihara, "Process for producing fructose-1,6-diphosphate." U.S. Patent US5094947, issued January, 1981.
n5:IUPAC-Name
n6:271B6480-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B6486-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6485-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B6482-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B6483-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6484-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B647E-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B647C-363D-11E5-9242-09173F13E4C5 n6:271B647F-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B647D-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B648C-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B648D-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B6487-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B6488-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B648A-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6489-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B648B-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B6492-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B6494-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B6495-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B6491-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B6490-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B6493-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B6481-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B648E-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B648F-363D-11E5-9242-09173F13E4C5